NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Crude Oil Rises 1%; Mustang Bio Shares Spike Higher

Published 17/06/2024, 17:16
© Reuters.  Crude Oil Rises 1%; Mustang Bio Shares Spike Higher
UK100
-
US500
-
FCHI
-
STOXX50
-
HK50
-
GC
-
SI
-
CL
-
AAN
-
SSEC
-
MBIO
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded mixed midway through trading, with the S&P 500 edging higher on Monday.

The Dow traded up 0.08% to 38,618.63 while the NASDAQ rose 0.20% to 17,724.07. The S&P 500 also rose, gaining, 0.24% to 5,444.69.

Check This Out: Top 4 Risk Off Stocks That May Rocket Higher In Q2

Leading and Lagging Sectors

Consumer staples shares jumped by 0.4% on Monday.

In trading on Monday, utilities shares fell by 1%.

Top Headline

The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.

Equities Trading UP

  • Mustang Bio, Inc. (NASDAQ:MBIO) shares shot up 240% to $0.4399 after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.
  • Shares of Allego N.V. (NASDAQ:ALLG) got a boost, surging 127% to $1.67 after the company and its majority shareholder, Meridiam, announced a transaction framework agreement under which Meridiam will launch a tender offer for all issued and outstanding Allego shares not owned by Meridiam, with the option to tender shares for $1.70 per share in cash.
  • The Aaron’s Company, Inc. (NYSE:AAN) shares were also up, gaining 32% to $9.98 after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.
Equities Trading DOWN

  • Aerovate Therapeutics, Inc. (NASDAQ:AVTE) shares dropped 91% to $2.21. Aerovate Therapeutics released topline results from the Phase 2b portion of the IMPAHCT Phase 2b/3 trial of AV-101, a dry powder inhaled formulation of imatinib, for pulmonary arterial hypertension (PAH).
  • Shares of Workhorse Group Inc. (NASDAQ:WKHS) were down 20% to $2.3950 as the stock begins trading on a split-adjusted basis. Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company's annual meeting of stockholders in May.
  • Ovid Therapeutics Inc (NASDAQ:OVID) was down, falling 68% to $1.04 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint
Also Check This Out: How To Earn $500 A Month From Steelcase Stock Ahead Of Q1 Earnings Report

Commodities

In commodity news, oil traded up 1.2% to $79.36 while gold traded down 0.4% at $2,339.00.

Silver traded up 0.1% to $29.485 on Monday, while copper fell 1.7% to $4.4210.

Euro zone

European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.02%, Germany's DAX rose 0.27% and France's CAC 40 gained 0.67%. Spain's IBEX 35 Index fell 0.50%, while London's FTSE 100 slipped 0.15%.

Wages in the Eurozone increased 5.3% year-over-year in the first quarter, while hourly labor costs climbed by 5.1% annually in the quarter.

Spain’s trade gap widened to EUR 4.7 billion in April from EUR 4.4 billion in the year-ago month. Italy's annual inflation rate came in unchanged at 0.8% in May.

Asia Pacific Markets

Asian markets closed lower on Monday, with Japan's Nikkei falling 1.83%, Hong Kong's Hang Seng Index declining 0.03% and China's Shanghai Composite Index dipping 0.55%.

China’s retail sales climbed by 3.7% year-over-year in May, while industrial production rose by 5.6% year-over-year in May. China's new home prices fell by 3.9% year-over-year during the month of May. The People's Bank of China kept the interest rate unchanged at 2.50% during its recent meeting. Japanese core machinery orders slipped l 2.9% month-over-month to 885.3 billion yen in April.

Economics

The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.

Now Read This: This Analyst With 86% Accuracy Rate Sees Over 13% Upside In Alphabet – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.